Vanda Pharmaceuticals to Present at Jefferies Inaugural Biotech CNS/Neuro Summit

Vanda Pharmaceuticals Inc., a leading global biopharmaceutical company, has announced its participation in the Jefferies Inaugural Biotech CNS/Neuro Summit, taking place in New York City on October 11, 2023. The company’s corporate presentation is scheduled for 1:30 p.m. Eastern Time.

Investors and interested parties can access the live corporate presentation on Vanda’s official website, www.vandapharma.com. By clicking on the Investors tab and following the link under Recent Events, viewers can join the session. It is recommended to register, download, and install any necessary software or presentations at least 15 minutes prior to the start time. The archived conference will also be available on Vanda’s website for approximately 30 days.

Vanda Pharmaceuticals Inc. is dedicated to developing and commercializing innovative therapies to address unmet medical needs and improve patients’ lives. The company’s participation in the Jefferies Inaugural Biotech CNS/Neuro Summit highlights its commitment to advancing research and development in the field of central nervous system and neurological disorders.

For more information about Vanda Pharmaceuticals Inc. and its ongoing efforts, please visit their website at www.vandapharma.com. Stay updated by following them on X @vandapharma.

Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com